ปรัชญา: ความสำเร็จที่แท้จริงอยู่ที่การนำความรู้ไปประยุกต์ใช้เพื่อประโยชน์สุขแก่มวลมนุษยชาติ

You are here

ผลงานวิจัย พศ.2556 (2013)

Division of Infectious Diseases (สาขาวิชาโรคติดเชื้อ

  1. Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy. Guy R, Wand H, McManus H, Vonthanak S, Woolley I, Honda M, Read T, Sirisanthana T, Zhou J, Carr A; Australia HIV Observational Database (AHOD) and Treat Asia HIV Observation Database (TAHOD).. AIDS Patient Care STDS. 2013 Dec;27(12):681-91.
  2. Factors determining the appropriateness of ceftriaxone usage at the emergency room of a university hospital in Thailand. Phuphuakrat A, Kiertiburanakul S, Malathum K. J Med Assoc Thai. 2013 Jul;96(7):773-81.
  3. Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism. Sukasem C, Manosuthi W, Koomdee N, Santon S, Jantararoungtong T, Prommas S, Chamnanphol M, Puangpetch A, Sungkanuparph S. Infection. 2014 Jun;42(3):469-74.  
  4. Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy. Asdamongkol N, Phanachet P, Sungkanuparph S. Jpn J Infect Dis. 2013;66(6):469-74.
  5. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates. Phuphuakrat A, Phawattanakul S, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. HIV Med. 2014 May;15(5):269-75.  
  6. Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. Fenner L, Ballif M, Graber C, Nhandu V, Dusingize JC, Cortes CP, Carriquiry G, Anastos K, Garone D, Jong E, Gnokoro JC, Sued O, Ajayi S, Diero L, Wools-Kaloustian K, Kiertiburanakul S, Castelnuovo B, Lewden C, Durier N, Sterling TR, Egger M; International epidemiological Databases to Evaluate AIDS (IeDEA).. PLoS One. 2013 Oct 17;8(10):e77697.
  7. Fungal appendicitis: a case series and review of the literature. Larbcharoensub N, Boonsakan P, Kanoksil W, Wattanatranon D, Phongkitkarun S, Molagool S, Watcharananan SP. Southeast Asian J Trop Med Public Health. 2013 Jul 4;44(4):681-9. Review.
  8. Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient. Larbcharoensub N, Chongtrakool P, Wirojtananugoon C, Watcharananan SP, Sumethkul V, Boongird A, Jirasiritham S. Southeast Asian J Trop Med Public Health. 2013 May;44(3):484-9.
  9. Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients. Srisawasdi P, Suwalak T, Sukasem C, Chittamma A, Pocathikorn A, Vanavanan S, Puangpetch A, Santon S, Chantratita W, Kiertiburanakul S, Kroll MH. Am J Clin Pathol. 2013 Oct;140(4):506-15.
  10. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database. Han SH, Zhou J, Lee MP, Zhao H, Chen YM, Kumarasamy N, Pujari S, Lee C, Omar SF, Ditangco R, Phanuphak N, Kiertiburanakul S, Chaiwarith R, Merati TP, Yunihastuti E, Tanuma J, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Database.. HIV Med. 2014 Feb;15(2):77-85.  
  11. Rilpivirine resistance-associated mutations among antiretroviral-naive patients infected with HIV-1 in Asia. Sungkanuparph S, Jiamsakul A, Kiertiburanakul S, Sirivichayakul S, Praparattanapan J, Kantor R; TREAT Asia Studies to Evaluate Resistance.. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):e98-100.  
  12. Clinical and radiologic manifestations of pulmonary cryptococcosis in immunocompetent patients and their outcomes after treatment. Suwatanapongched T, Sangsatra W, Boonsarngsuk V, Watcharananan SP, Incharoen P. Diagn Interv Radiol. 2013 Nov-Dec;19(6):438-46.  
  13. Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region. Wright S, Boyd MA, Yunihastuti E, Law M, Sirisanthana T, Hoy J, Pujari S, Lee MP, Petoumenos K; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific HIV Observational Database (APHOD).. PLoS One. 2013 Jun 28;8(6):e64902.
  14. Would a CYP2B6 test help HIV patients being treated with efavirenz? Sukasem C, Sungkanuparph S. Pharmacogenomics. 2013 Jul;14(9):999-1001.
  15. Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients. Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li PC, Kantipong P, Lee C, Ratanasuwan W, Kamarulzaman A, Sohn AH, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies.. PLoS One. 2013 Jun 27;8(6):e62057.
  16. Surveillance of transmitted HIV drug resistance in antiretroviral-naive patients aged less than 25 years, in Bangkok, Thailand. Sungkanuparph S, Pasomsub E, Chantratita W. J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):12-4.
  17. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand. Kyaw NL, Thanachartwet V, Kiertiburanakul S, Desakorn V, Chamnanchanunt S, Chierakul W, Manosuthi W, Pitisuttithum P, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2013 Mar;44(2):232-43.
  18. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJ, Nguyen BY, Teppler H; BENCHMRK Study Teams.. Lancet Infect Dis. 2013 Jul;13(7):587-96.
  19. Evaluation of multiplex PCR with enhanced spore germination for detection of Clostridium difficile from stool samples of the hospitalized patients. Chankhamhaengdecha S, Hadpanus P, Aroonnual A, Ngamwongsatit P, Chotiprasitsakul D, Chongtrakool P, Janvilisri T. Biomed Res Int. 2013;2013:875437.  
  20. Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis. Phuphuakrat A, Ngamjanyaporn P, Nantiruj K, Luangwedchakarn V, Malathum K. J Microbiol Immunol Infect. 2016 Feb;49(1):150-3. D
  21. Rothia mucilaginosa prosthetic device infections: a case of prosthetic valve endocarditis. Bruminhent J, Tokarczyk MJ, Jungkind D, DeSimone JA Jr. J Clin Microbiol. 2013 May;51(5):1629-32.
  22. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM; INSIGHT SMART Study Group.. PLoS One. 2013;8(2):e56249.
  23. Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database. Byakwaga H, Petoumenos K, Ananworanich J, Zhang F, Boyd MA, Sirisanthana T, Li PC, Lee C, Mean CV, Saphonn V, Omar SF, Pujari S, Phanuphak P, Lim PL, Kumarasamy N, Chen YM, Merati TP, Sungkanuparph S, Ditangco R, Oka S, Tau G, Zhou J, Law MG, Emery S. J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):270-7.
  24. Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. Rockstroh JK, DeJesus E, Lennox JL, Yazdanpanah Y, Saag MS, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P; STARTMRK Investigators.. J Acquir Immune Defic Syndr. 2013 May 1;63(1):77-85.
  25. Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients. Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Antimicrob Agents Chemother. 2013 Feb;57(2):1019-24.
  26. Listeria monocytogenes cholecystitis: a possible new syndrome. Bruminhent J, Lynch TK, Gefen J, Santoro J. Am J Med Sci. 2013 May;345(5):414-7.  
  27. Transmitted HIV drug resistance in Asia. Sohn AH, Srikantiah P, Sungkanuparph S, Zhang F. Curr Opin HIV AIDS. 2013 Jan;8(1):27-33.
  28. HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection. Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. J Med Virol. 2013 Feb;85(2):194-9.
  29. A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. Matthews P, Alpert M, Rahav G, Rill D, Zito E, Gardiner D, Pedersen R, Babinchak T, McGovern PC; Tigecycline 900 cSSSI Study Group.. BMC Infect Dis. 2012 Nov 12;12:297.
  30. Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CK, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM; TREAT Asia Studies to Evaluate Resistance (TASER) and The TREAT Asia HIV Observational Database.. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):293-300.  
  31. Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis. Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, Lee CK, Kamarulzaman A, Ratanasuwan W, Ditangco R, Singtoroj T, Sungkanuparph S; TREAT Asia Studies to Evaluate Resistance – Monitoring Study (TASER-M).. BMC Res Notes. 2012 Oct 24;5:582.  
  32. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting. Than NN, Sungkanuparph S, Maek-A-Nantawat W, Kaewkungwal J, Pitisuttithum P. Southeast Asian J Trop Med Public Health. 2012 May;43(3):646-51.
  33. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; HIV STAR Study Group.. Antivir Ther. 2012;17(7):1351-61. doi: 10.3851/IMP2443. Erratum in: Antivir Ther. 2012;17(7):1389-90.
  34. Adult-onset immunodeficiency in Thailand and Taiwan. Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM. N Engl J Med. 2012 Aug 23;367(8):725-34.
  35. Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRK. DeJesus E, Rockstroh JK, Lennox JL, Saag MS, Lazzarin A, Zhao J, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P; STARTMRK Investigators.. HIV Clin Trials. 2012 Jul-Aug;13(4):228-32.
  36. A superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings. Chotiprasitsakul D, Janvilisri T, Kiertiburanakul S, Watcharananun S, Chankhamhaengdecha S, Hadpanus P, Malathum K. Jpn J Infect Dis. 2012 Jul;65(4):326-9.
  37. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathak SR, Soud FA, Chillag KL, Mutanhaurwa R, Chirwa LI, Kasonde M, Abebe D, Buliva E, Gvetadze RJ, Johnson S, Sukalac T, Thomas VT, Hart C, Johnson JA, Malotte CK, Hendrix CW, Brooks JT; TDF2 Study Group.. N Engl J Med. 2012 Aug 2;367(5):423-34.
  38. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP; GS-236-0103 Study Team.. Lancet. 2012 Jun 30;379(9835):2429-38.
  39. Clinical characteristics of HIV-infected patients who survive after the diagnosis of HIV infection for more than 10 years in a resource-limited setting. Kiertiburanakul S, Luengroongroj P, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):361-5.
  40. HIV-1 drug resistance at virological failure versus immunological failure among patients failing first-line antiretroviral therapy in a resource-limited setting. Sungkanuparph S, Win MM, Kiertiburanakul S, Phonrat B, Maek-a-nantawat W. Int J STD AIDS. 2012 May;23(5):316-8.
  41. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study. Manosuthi W, Mankatitham W, Lueangniyomkul A, Thongyen S, Likanonsakul S, Suwanvattana P, Thawornwan U, Suntisuklappon B, Nilkamhang S, Sungkanuparph S; TIME Study Team.. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):377-83. D
  42. Population pharmacokinetics of vancomycin in Thai patients. Purwonugroho TA, Chulavatnatol S, Preechagoon Y, Chindavijak B, Malathum K, Bunuparadah P. ScientificWorldJournal. 2012;2012:762649.
  43. Influenza A (H1N1) 2009 reinfection in Thailand. Trakulsrichai S, Watcharananan SP, Chantratita W. J Infect Public Health. 2012 Apr;5(2):211-4.  
  44. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials. Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K; ECHO and THRIVE Study Groups.. J Antimicrob Chemother. 2012 Aug;67(8):2020-8.  
  45. Evaluation of real-time polymerase chain reaction for detection of the 16S ribosomal RNA gene of Mycobacterium tuberculosis and the diagnosis of cervical tuberculous lymphadenitis in a country with a high tuberculosis incidence. Linasmita P, Srisangkaew S, Wongsuk T, Bhongmakapat T, Watcharananan SP. Clin Infect Dis. 2012 Aug;55(3):313-21.  
  46. HIV drug resistance interpreted by cumulative versus last genotypes in HIV-infected patients with multiple treatment failures. Punyacam P, Iemwimangsa N, Chantratita W, Sukasem C, Sungkanuparph S. Curr HIV Res. 2012 Apr;10(3):271-4.
  47. Cytomegalovirus viremia after kidney transplantation in Thailand: predictors of symptomatic infection and outcome. Watcharananan SP, Louhapanswat S, Chantratita W, Jirasiritham S, Sumethkul V. Transplant Proc. 2012 Apr;44(3):701-5.  
  48. Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD. Zhou J, Tanuma J, Chaiwarith R, Lee CK, Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari S, Choi JY, Parwati Merati T, Yunihastuti E, Li PC, Kamarulzaman A, Nguyen VK, Thuy Pham TT, Lim PL. AIDS Res Treat. 2012;2012:375217.
  49. Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand. Sungkanuparph S, Sukasem C, Kiertiburanakul S, Pasomsub E, Chantratita W. J Int AIDS Soc. 2012 Mar 12;15(1):12.
  50. Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure. Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. AIDS Res Ther. 2012 Mar 13;9(1):8.  
  51. Severe nonfebrile dengue infection in an adolescent after postoperative kidney transplantation: a case report. Tangnararatchakit K, Tirapanich W, Tapaneya-Olarn W, Sumethkul V, Sirachainan N, Watcharananan S, Leenanupunth C, Yoksan S, Chuansumrit A. Transplant Proc. 2012 Jan;44(1):303-6.
  52. Adrenal histoplasmosis: a case series and review of the literature. Larbcharoensub N, Boonsakan P, Aroonroch R, Rochanawutanon M, Nitiyanant P, Phongkitkarun S, Poonvutikul S, Watcharananan SP, Ngarmukos C. Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):920-5.
  53. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-Perez J, Hemingway-Foday J, Law M; Western Africa, Eastern Africa, Southern Africa, Caribbean and Central and South America, and Asia Pacific Regions of the International Epidemiologic Databases to Evaluate AIDS-IeDEA.. J Int AIDS Soc. 2012 Jan 30;15(1):5.
  54. Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.Lim PL, Zhou J, Ditangco RA, Law MG, Sirisanthana T, Kumarasamy N, Chen YM, Phanuphak P, Lee CK, Saphonn V, Oka S, Zhang F, Choi JY, Pujari S, Kamarulzaman A, Li PC, Merati TP, Yunihastuti E, Messerschmidt L, Sungkanuparph S; TREAT Asia HIV Observational Database.. J Int AIDS Soc. 2012 Jan 26;15(1):1.
  55. Epidemiology of bloodstream infections and predictive factors of mortality among HIV-infected adult patients in Thailand in the era of highly active antiretroviral therapy. Kiertiburanakul S, Watcharatipagorn S, Chongtrakool P, Santanirand P. Jpn J Infect Dis. 2012;65(1):28-32.
  56. Vitamin D insufficiency and deficiency among HIV-1-infected patients in a tropical setting. Wiboonchutikul S, Sungkanuparph S, Kiertiburanakul S, Chailurkit LO, Charoenyingwattana A, Wangsomboonsiri W, Chantratita W, Ongphiphadhanakul B. J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):305-10.
  57. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients. Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, Sungkanuparph S, Mundy LM. Int J Tuberc Lung Dis. 2012;16(3):336-41
  58. Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand. Kiertiburanakul S, Suebsing S, Kehachindawat P, Apivanich S, Somsakul S, Sathapatayavongs B, Malathum K. J Hosp Infect. 2012 Feb;80(2):173-5.
  59. Discrepancies between WHO 2009 and IAS-USA 2009 lists for determining the rate of transmitted HIV-1 drug resistance: a prospective study. Sungkanuparph S, Kiertiburanakul S, Sukasem C, Chantratita W. J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):e3-5
  60. Optimal timing of antiretroviral therapy initiation in patients coinfected with HIV and tuberculosis. Kiertiburanakul S, Manosuthi W, Sungkanuparph S. Expert Rev Clin Pharmacol. 2011 Mar;4(2):143-6.  
  61. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. J Infect. 2012 Jan;64(1):68-75. doi: 10.1016/j.jinf.2011.11.002.

หน่วยต่อมไร้ท่อและเมตะบอลิซึมส์

หน่วยโรคไต

  •  

หน่วยโรคหัวใจ

  •  

หน่วยโรคปอด

  •  

หน่วยโลหิตวิทยา

  •  

หน่วยประสาทวิทยา

  •  

หน่วยโรคทางเดินอาหาร

  •  

หน่วยเภสัชวิทยาและพิษวิทยาคลินิก

  •  

หน่วยโภชนวิทยาและชีวเคมีทางการแพทย์

  •  

หน่วยโรคภูมิแพ้อิมมูโนวิทยาและโรคข้อ

  •  

หน่วยโรคผิวหนัง

  •  

หน่วยมะเร็งวิทยา

  •  

หน่วยเวชพันธุศาสตร์

  •  

หน่วยเวชศาสตร์ผู้สูงอายุ

  •